Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of APG-3288 in Patients With Relapsed/Refractory Hematological Malignancies

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT07424833
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:28:23.271924+00:00
Published At
2026-02-20T00:00:00+00:00
Record Updated At
2026-02-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Relapsed/Refractory Hematological Malignancies", "Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL", "Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation)", "Relapsed/Refractory Mantle Cell Lymphoma (MCL)", "Relapsed/Refractory Waldenstr\u00f6m Macroglobulinemia (WM)", "Relapsed/Refractory Marginal Zone Lymphoma (MZL)", "Relapsed/Refractory Follicular Lymphoma (FL)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-02-20"
protocolSection.identificationModule.nctId
"NCT07424833"
protocolSection.identificationModule.officialTitle
"A Phase I Study to Evaluate the Safety, Pharmacokinetics, and Preliminary Efficacy of APG-3288 in Patients With Relapsed/Refractory Hematological Malignancies"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Relapsed/Refractory Hematological Malignancies (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia (CLL/SLL (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL; Including Richter Transformation) (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Mantle Cell Lymphoma (MCL) (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Waldenström Macroglobulinemia (WM) (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Marginal Zone Lymphoma (MZL) (protocolSection.conditionsModule.conditions)
  • Relapsed/Refractory Follicular Lymphoma (FL) (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.